Allergan Dodges Class Action Over Pricey Eye Drops

Law360, Los Angeles (January 28, 2014, 9:21 PM EST) -- A Missouri federal judge threw out a putative class action alleging Allergan USA Inc. overcharged consumers for chronic dry eye treatment Restasis by filling dispensers with pricey excess medicine, holding Tuesday that the plaintiff failed to state a claim under a Missouri consumer law.

U.S. District Judge Audrey G. Fleissig granted Allergan and its affiliates' motion to dismiss the suit, brought by Fancine Thompson a year ago, ruling that smaller amounts of the drug wouldn’t necessarily make it less expensive to consumers.

“[T]he allegation that including...
To view the full article, register now.




Case Information

Case Title

Thompson v. Allergan USA, Inc. et al

Case Number



Missouri Eastern

Nature of Suit

Fraud or Truth-In-Lending


Audrey G. Fleissig

Date Filed

January 7, 2013

Law Firms


Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.